Glyconics
Cambridge
About Glyconics
Glyconics Ltd is an innovative diagnostics company which has developed a novel approach to the diagnosis and monitoring of chronic and acute diseases including respiratory disease. The new device uses fourier transform infrared spectroscopy (FITR) to analyse sputum (saliva) samples for specific biomarkers, characteristic of chronic obstructive pulmonary disease (COPD).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2021)
- Website: glyconics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/glyconics-32557 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.